article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Barrett at the Center for Gamma Ray Imaging.

article thumbnail

Beating the Big C

Pharmaceutical Technology

” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” However, there’s still plenty of cancers where treatment can only prolong life by two to three months and then only with side effects that bring up serious quality of life issues. We’re on the right path.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.

article thumbnail

Direct to Patient Healthcare

Healthcare Success

Yeah, for some folks, and you know, and I think my, you know, my role was, I started at Mayo clinic in public affairs on the media relations team in 2000, and then 2003 became manager of the media relations team, and then 2005 heard about this new thing called podcasting at the time which had been invented a year before. It was scary.